Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
iShares Genomics Immunology and Healthcare ETF IDNA
$23.91
-$0.32 (-1.32%)
На 18:01, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
34.66
-
week52low
22.09
-
Revenue
-
P/E TTM
-
Beta
0.00000000
-
EPS
10.25000000
-
Last Dividend
0.13600000
-
Next Earnings Date
07 мая 2023 г. в 03:23
Описание компании
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Will 2023 be the Year of Cathie Wood ETFs?
Zacks Investment Research
24 янв 2023 г. в 09:02
Cathie Wood, famous for the success of Ark Investment???s winning products, had faced a miserable fate in 2022.
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha
11 янв 2023 г. в 18:09
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
IDNA: Healthcare Dashboard For November
Seeking Alpha
16 ноя 2022 г. в 12:26
The pharmaceutical and biotechnology subsector is undervalued by about 17% relative to 11-year averages. Healthcare equipment and life science tools are overvalued by about 25% regarding the same metrics.
BlackRock Zeros in on Themed ETFs
ETFcom
09 сент 2022 г. в 15:28
The category represents a rapidly growing portion of the issuer's lineup.
Why Now Could Be The Time To Consider Neuroscience Investments
Seeking Alpha
27 авг 2022 г. в 04:45
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.